Cell Metabolism , 21(3), 443454
Garvey explains how combining amylin and GLP-1 receptor agonism may enhance weight loss and glycemic control while maintaining tolerability, and explores the potential role of amylin therapies in the future management of obesity and type 2 diabetes
route-dependent Typical dosing Daily subcutaneous injection (evening) Once or twice weekly (with DAC)
Abstract Although approached through many concepts, the pleiotropic healing issue, specifically, maintaining/reestablishing tissue integrity, remains a central challenge in pharmacology, particularly when the process is misdirected or not properly controlled
Women with eventually diagnosed endometriosis average 12.2 healthcare visits in the five years before diagnosis, compared to 4.1 visits for matched controls